NasdaqGS - Delayed Quote USD

Embecta Corp. (EMBC)

14.45 +0.25 (+1.76%)
At close: May 17 at 4:00 PM EDT
14.45 0.00 (0.00%)
After hours: May 17 at 6:29 PM EDT
Loading Chart for EMBC
DELL
  • Previous Close 14.20
  • Open 14.28
  • Bid 14.43 x 100
  • Ask 14.48 x 100
  • Day's Range 13.96 - 14.63
  • 52 Week Range 9.93 - 28.99
  • Volume 369,436
  • Avg. Volume 431,520
  • Market Cap (intraday) 833.334M
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 11.84
  • EPS (TTM) 1.22
  • Earnings Date Aug 6, 2024 - Aug 12, 2024
  • Forward Dividend & Yield 0.60 (4.15%)
  • Ex-Dividend Date May 28, 2024
  • 1y Target Est 15.00

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

www.embecta.com

2,200

Full Time Employees

September 30

Fiscal Year Ends

Recent News: EMBC

Performance Overview: EMBC

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EMBC
22.87%
S&P 500
11.18%

1-Year Return

EMBC
48.24%
S&P 500
29.04%

3-Year Return

EMBC
69.90%
S&P 500
17.55%

5-Year Return

EMBC
69.90%
S&P 500
17.55%

Compare To: EMBC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EMBC

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    833.33M

  • Enterprise Value

    2.17B

  • Trailing P/E

    11.84

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.74

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.92

  • Enterprise Value/EBITDA

    11.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.20%

  • Return on Assets (ttm)

    9.74%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.13B

  • Net Income Avi to Common (ttm)

    70.2M

  • Diluted EPS (ttm)

    1.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    299.8M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    44.26M

Research Analysis: EMBC

Company Insights: EMBC

Research Reports: EMBC

People Also Watch